Pacritinib in CMML
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06159491 |
|
Recruitment Status :
Not yet recruiting
First Posted : December 6, 2023
Last Update Posted : December 6, 2023
|
Sponsor:
Douglas Tremblay
Collaborator:
Sobi, Inc.
Information provided by (Responsible Party):
Douglas Tremblay, Icahn School of Medicine at Mount Sinai
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | July 2025 |
| Estimated Study Completion Date : | May 2027 |